Article
Bcl-2 antagonist killer 1 (BAK1) polymorphisms influence the risk of developing autoimmune rheumatic diseases in women.
Annals of the rheumatic diseases - 1 Feb 2010
Delgado-Vega A M, Castiblanco J, Gómez L M, Diaz-Gallo L-M, Rojas-Villarraga A, Anaya J-M
Abstract excerpt
OBJECTIVE: Bcl-2 antagonist killer 1 (BAK1) is a Bcl-2 family proapoptotic member suggested as a candidate gene for autoimmune diseases. The influence of BAK1 polymorphisms on the risk of developing autoimmune rheumatic diseases (AIRDs) in women was investigated. METHODS: A total of 719 Colombian women were included in the present study: 209 had systemic lupus erythematosus, 99 primary Sjögren syndrome, 159...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
